ARGX-113, an Investigational Therapy for Myasthenia Gravis, Shows Promise in Phase 2 Trial
An investigational treatment for myasthenia gravis, ARGX-113 (efgartigimod), being developed by the Dutch pharmaceutical firm argenx, was found to be…
Articles by Magdalena Kegel
MG Respiratory Failure Requires Specific Treatments in the ER, Review Contends
Myasthenic crisis is a common complication in patients with myasthenia gravis (MG), marked by exacerbation of MG symptoms and respiratory…
Rituxan Is Far Cheaper Than Other Therapy Options Over Myasthenia Gravis Patients’ Lifetimes, Study Shows
The cost of Genentech’s myasthenia gravis treatment Rituxan (rituximab) is half that of the blood purification process known as plasmapheresis…
Thymus Removal Is an Effective Myasthenia Gravis Treatment, Chinese Researchers Argue
Removing the thymus is an effective way to treat people with ocular myasthenia gravis, according to an analysis of previously published data…
Researchers Gain Insight Into How Myasthenia Gravis Antibodies Destroy Receptor Vital to Movement
University of Southern California researchers have gained insight into how antibodies connected with a disease known as myasthenia gravis…